REGADENOSON MONOHYDRATE

Regadenoson Monohydrate is a research-grade compound used in advanced pharmaceutical and biochemical studies. Chemical & Pharmacological Characteristics Experimental behavior is governed by solubility, stability, ionization state, and matrix interactions. Proper formulation control is essential. Mechanism of Action No single receptor-driven mechanism is assumed; observed effects are concentration- and context-dependent. It is primarily applied to investigate compound-specific mechanisms, physicochemical behavior, and analytical or formulation-relevant characteristics under controlled laboratory conditions.

SKU: c0291e2fabd9 Category:

Product Description


Chemical & Pharmacological Characteristics

Experimental behavior is governed by solubility, stability, ionization state, and matrix interactions. Proper formulation control is essential.

Mechanism of Action

No single receptor-driven mechanism is assumed; observed effects are concentration- and context-dependent.

Interpretation should include matched controls to separate direct chemical effects from secondary stress responses.

Advanced Research Applications

  • Analytical reference and quality control
  • Formulation development and stability screening
  • Compatibility testing with excipients and packaging
  • Comparative toxicology benchmarking
  • Documentation support for R&D workflows

Toxicodynamics & Cellular Hazard Spectrum

  • Nonspecific cytotoxicity at high exposure
  • Solubility or aggregation artifacts
  • Matrix-dependent assay interference
  • Handling-related irritation risk
  • Dispose according to laboratory waste regulations

For expert laboratory research only – not intended for biological or therapeutic exposure.

Datasheet


Molecular Formula

C15H18N8O5

Molecular Weight

390.35 g/mol

CAS Number

313348-27-5

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Regadenoson; 313348-27-5; Lexiscan; Rapiscan; Regadenoson anhydrous

IUPAC/Chemical Name

1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide

InChl Key

LZPZPHGJDAGEJZ-AKAIJSEGSA-N

InChl Code

InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/219024; small-molecule

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download